Revance Therapeutics (NASDAQ:RVNC) Price Target Lowered to $8.00 at The Goldman Sachs Group theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
-Contineum is focused on leading the Neuroscience, Inflammation and Immunology field-
-Successful completion of Initial Public Offering with strong syndicate of existing and new investors-
.
Needham & Company LLC Cuts Revance Therapeutics (NASDAQ:RVNC) Price Target to $12.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Mizuho Lowers Revance Therapeutics (NASDAQ:RVNC) Price Target to $8.00 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.